Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome.
about
Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantationRAS diseases in childrenCurrent management of juvenile myelomonocytic leukemia and the impact of RAS mutationsRASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia.Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia.Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur womenExpressional alterations in functional ultra-conserved non-coding RNAs in response to all-trans retinoic acid--induced differentiation in neuroblastoma cells.Analysis of PTEN methylation patterns in soft tissue sarcomas by MassARRAY spectrometry.IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells.Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia.Identification of DNA methylation changes at cis-regulatory elements during early steps of HSC differentiation using tagmentation-based whole genome bisulfite sequencingEpigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia.A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma.Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study.Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.Epigenetic dysregulation of the erythropoietic transcription factor KLF1 and the beta-like globin locus in juvenile myelomonocytic leukemia.Turning the tide in myelodysplastic/myeloproliferative neoplasms.VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in mice.CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia.Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance.Deficiency of CREB and over expression of miR-183 in juvenile myelomonocytic leukemia.Treatment of disease recurrence after allogeneic hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: a great challenge still to be won.RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia.Yolk sac erythromyeloid progenitors expressing gain of function PTPN11 have functional features of JMML but are not sufficient to cause disease in mice.Whole Genome MBD-seq reveals different CpG methylation patterns in Azacytidine-treated Juvenile Myelomonocytic Leukaemia (JMML) patients.Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome.Diagnosis and treatment of juvenile myelomonocytic leukemia.
P2860
Q26851000-EF957730-F982-4018-909F-D4B9C0CCC7B2Q28252058-96CDFF3E-309E-4704-82B3-A9DE7AED86BBQ28263773-CBCAD7CA-CA58-420F-A5B9-004753BBBF07Q34212680-D4652C7A-12A7-4C45-BECF-A34CB7C71B54Q34217900-1A301672-86EA-4DE5-B3ED-A79525D78950Q34425118-C04F658E-5B10-4D72-B2F1-677DCC3C0FEEQ34658931-D5DA111A-DA86-4D2B-910F-AD796217F7DDQ34729972-2B545D0F-7BDB-49C2-B479-901B9BCF8B4AQ35717574-2881FA61-0E8B-49D1-9F5A-18BFBC9CB5D9Q35882742-44BBFAF4-3CB2-4443-AECB-AB78D6FFAEEEQ36183871-0FF33C81-C423-4B09-9CC5-7FC958E99EF6Q36838867-D85FE0D7-E728-4175-880A-6E333A4962DDQ36839476-448CD06F-8D22-4A76-9064-69E198433CB6Q37330968-D8B6F084-2F30-49B0-B693-EDE3A5AB3BECQ37349392-29AF8077-B7F8-4636-AAFC-60A85EB24D15Q38658020-C0D09DAE-A11C-4D18-8A9A-05D98337C7A9Q38712988-B4CFD16B-36C3-4388-8D83-D838C30FE605Q38728879-9DF8A378-8F48-45F0-AA68-54421DD066A8Q39784106-CE8F47B2-F1E4-4E22-81F3-59E94C0E9A04Q41342990-FFE4BB04-F5AD-4877-A4A4-06A13A81FDD9Q43085895-8A4A585F-0C76-49CA-AED3-69E4F199A85EQ44650138-FBC5FB6F-8742-4D39-BA63-66EDD2D3060CQ47098092-DC50FCE9-1E23-48A1-A4B9-9353922F8938Q47134904-03374005-6143-4CF7-AF34-8CBEED820A2AQ47702122-146A1C3C-EF62-450C-B992-0F8863B7DF91Q48298146-CC29548D-0856-4A42-AE01-E43475004A25Q48557504-EE86CD4B-190D-42C3-A696-4603CBC7A23AQ52661221-CE56C98B-B137-4DDF-92A9-A9FAA991DB38Q54329346-57BE1338-3597-4A9D-B0CF-B07D2E90EEE5Q55059769-0C057EBA-941B-4549-94A4-443851ECE3C0
P2860
Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Aberrant DNA methylation chara ...... ic leukemia with poor outcome.
@en
Aberrant DNA methylation chara ...... ic leukemia with poor outcome.
@nl
type
label
Aberrant DNA methylation chara ...... ic leukemia with poor outcome.
@en
Aberrant DNA methylation chara ...... ic leukemia with poor outcome.
@nl
prefLabel
Aberrant DNA methylation chara ...... ic leukemia with poor outcome.
@en
Aberrant DNA methylation chara ...... ic leukemia with poor outcome.
@nl
P2093
P50
P1433
P1476
Aberrant DNA methylation chara ...... ic leukemia with poor outcome.
@en
P2093
Anna R Poetsch
Barbara De Moerloose
Brigitte Strahm
Charlotte M Niemeyer
Christian Flotho
Christiane Olk-Batz
Christoph Plass
Dorota Wojcik
European Working Group of Myelodysplastic Syndromes in Childhood (EWOG-MDS)
Eva Bergstraesser
P304
P356
10.1182/BLOOD-2010-08-298968
P407
P577
2011-03-15T00:00:00Z